tetano
Editor, Senior Moderator
Case Rep Cardiol
. 2022 Aug 18;2022:1157728.
doi: 10.1155/2022/1157728. eCollection 2022.
Ventricular Tachycardia or Fibrillation Storm in Coronavirus Disease
Muhammad H Khan[SUP] 1 [/SUP], Obadah Aqtash[SUP] 2 [/SUP], David M Harris[SUP] 2 [/SUP], Alexandru I Costea[SUP] 2 [/SUP], Myron C Gerson[SUP] 2 [/SUP]
Affiliations
Abstract
Ventricular tachycardia (VT) or ventricular fibrillation (VF) storm associated with severe acute respiratory syndrome coronavirus 2 infection is a potentially fatal complication; the correlation of these 2 disorders, however, has not been well studied. This retrospective case series examined outcomes of 2 patients who were admitted for repeated implantable cardioverter-defibrillator shocks with or without syncope and observed to have VT/VF storms with COVID-19. Mechanisms of VT/VF storms in COVID-19 are multifactorial including myocarditis, systemic inflammation, hyperadrenergic state, hemodynamic instability, hypoxia, acidosis, and proarrhythmic drugs. A higher incidence of VT/VF storm is observed in patients with comorbidities and those requiring critical care, with some studies reporting increased mortality. In our cohort, 1 of the 2 patients succumbed to the complications from COVID-19, and the other patient was discharged to home in stable condition. Monitoring of life-threatening arrhythmias in the setting of COVID-19 may need to be adopted to prevent morbidity and mortality.
. 2022 Aug 18;2022:1157728.
doi: 10.1155/2022/1157728. eCollection 2022.
Ventricular Tachycardia or Fibrillation Storm in Coronavirus Disease
Muhammad H Khan[SUP] 1 [/SUP], Obadah Aqtash[SUP] 2 [/SUP], David M Harris[SUP] 2 [/SUP], Alexandru I Costea[SUP] 2 [/SUP], Myron C Gerson[SUP] 2 [/SUP]
Affiliations
- PMID: 36032053
- PMCID: PMC9410984
- DOI: 10.1155/2022/1157728
Abstract
Ventricular tachycardia (VT) or ventricular fibrillation (VF) storm associated with severe acute respiratory syndrome coronavirus 2 infection is a potentially fatal complication; the correlation of these 2 disorders, however, has not been well studied. This retrospective case series examined outcomes of 2 patients who were admitted for repeated implantable cardioverter-defibrillator shocks with or without syncope and observed to have VT/VF storms with COVID-19. Mechanisms of VT/VF storms in COVID-19 are multifactorial including myocarditis, systemic inflammation, hyperadrenergic state, hemodynamic instability, hypoxia, acidosis, and proarrhythmic drugs. A higher incidence of VT/VF storm is observed in patients with comorbidities and those requiring critical care, with some studies reporting increased mortality. In our cohort, 1 of the 2 patients succumbed to the complications from COVID-19, and the other patient was discharged to home in stable condition. Monitoring of life-threatening arrhythmias in the setting of COVID-19 may need to be adopted to prevent morbidity and mortality.